SS-31 is a mitochondria-targeted tetrapeptide antioxidant studied for its protective effects on cellular bioenergetics. Research in aging and disease models has investigated its ability to reduce oxidative stress, stabilize cardiolipin, and improve mitochondrial function in contexts like neurodegeneration, cardiovascular issues, and muscle atrophy. It provides insights into mitochondrial dysfunction and therapeutic targeting.
For research use only.
